The Massachusetts Model of Health Reform in PracticeMass-Care & Massachusetts Physicians for a National Health ProgramOctober 2011The Massachusetts plan has been successful only in nominally
For more than 20 years, PNHPās Senior Health Policy Fellow Don McCanne, M.D. wrote a daily health policy update, taking an excerpt or quote from a health care news story or analysis and commenting on its significance to the single-payer movement.
PNHP has archived Dr. McCanneās listserv below; to read current daily analysis on a broad range of health justice topics, please visit the McCanne Health Justice Monitor website.
OECD/WHO report on the Swiss health system
NOTE: The Swiss have a universal, highly regulated system of social insurance based on nonprofit private insurance plans. Many consider their system to be superior
OECD/WHO report on the Swiss health system
It is not clear why so many in the U.S. are enamored of the Swiss health insurance system when this OECD/WHO report confirms that it
Wal-Mart squeezes employee health benefits
Wal-Mart Cuts Some Health Care BenefitsBy Steven Greenhouse and Reed AbelsonThe New York Times, October 20, 2011After trying to mollify its critics in recent years
Wal-Mart squeezes employee health benefits
A fundamental principle in the Affordable Care Act is that we would continue to rely very heavily on employer sponsored plans for the majority of
Ratings plummet for Medicare drug plans serving low-income patients
Lower Income Seniors See Star Ratings Drop in Available Medicare Prescription Drug Plans in 2012Avalere HealthOctober 19, 2011We can only speculate as to why there
Disarray of our health care workforce
National Center for Health Workforce AnalysisHealth Resources and Services Administration (HRSA)For at least a decade, the United States has experienced worsening workforce shortages in the
The value of $100,000 drugs
UK medical group rejects new skin cancer treatmentBy Maria ChengBloomberg Businessweek, October 14, 2011An independent British medical watchdog says the first treatment proven to help
The value of $100,000 drugs
Should a $126,000 drug (Yervoy, ipilimumab) that produced only a very minimal benefit in a small segment of patients studied, yet caused significant side affects,
The fundamental flaw with the IOM recommendation on benefits
Essential Health Benefits: Balancing Coverage and Costs (2011)Institute of Medicine"The committee concludes that the EHB (Essential Health Benefits) should be defined as a package that
The fundamental flaw with the IOM recommendation on benefits
When the Institute of Medicine (IOM) released its recommendations on the method for determining essential health benefits for the private plans to be offered in
URGENT: Sign letter of protest over IOM's skimpy health plan prescription
FOR ACTION TODAYA recent Quote of the Day message expressed alarm at the fact that the Institute of Medicine is recommending a grossly inadequate, skimpy,